Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Myriad Genetics, Inc. is a molecular diagnostic company specializing in precision medicine. It develops and offers genetic and genomic tests across oncology, women’s health, and pharmacogenomics to assess disease risk, guide treatment, and improve patient outcomes. Serving healthcare providers and patients, the company leverages innovative technologies, clinical evidence, and regulatory expertise to deliver actionable insights and support personalized healthcare.
This description was generated via AI from an annual report. Updated about 1 year ago.